
ETPPF
Healthcare · Biotechnology · $221.3M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 31, 2021 | Time not confirmed | 0.00 | -0.00 | — |
| Apr 30, 2021 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2021 | Time not confirmed | 0.00 | -0.00 | — |
| Oct 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Jul 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Apr 30, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Oct 31, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Jul 31, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Apr 30, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Oct 31, 2018 | Time not confirmed | 0.00 | -0.00 | — |
| Jul 31, 2018 | Time not confirmed | 0.00 | -0.01 | — |
e-Therapeutics plc operates as a drug discovery company in the United Kingdom. The company's Network-Driven Drug Discovery platform perform in silico phenotypic screens to generate sets of small molecules that are enriched in active compounds ensuring high in vitro hit rates in complex phenotypic screens; and Genome-Associated Interaction Networks platform to analyze genome-wide association study data, which…
| Apr 30, 2018 |
| Time not confirmed |
| 0.00 |
| -0.01 |
| — |
| Jan 31, 2018 | Time not confirmed | 0.00 | -0.01 | — |